bearish
Ascentage Pharma (亚盛医药) IPO: Some Issues with Banker Forecasts
625 Views01 Oct 2019 10:46
Ascentage Pharma is pre-marketing the USD 200 - 300 million IPO to list in Hong Kong. In our previous insight, we highlight the company's key...
SUMMARY
(Sign Up to Access)Get started on the Smartkarma Research Network with a complimentary Preview Pass to:
- Unlock all research summaries
- Follow top, independent analysts
- Receive personalised alerts and emails
- Access Briefings, Analytics, and Events
Upgrade anytime to our paid plans for full-length research, real-time analyst discussions, and more.
Join a thriving community of 45,000+ investors, including the top global asset managers managing over $13trn in assets.
or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 2-minute read)
Discussions
(Paid Plans Only)
- Ascentage Pharma (亚盛医药) IPO: Some Issues with Banker Forecasts01 Oct 2019
- Ascentage Pharma (亚盛医药) IPO: Thoughts on Valuation24 Jun 2019
- Ascentage Pharma (亚盛医药) IPO: Updates and Thoughts on HQP1351 (3rd Gen Bcr-Abl TKI)19 Jun 2019
x